Abstract:BACKGROUND AND OBJECTIVE:Colorectal cancer is one of the most common malignant cancers in the world. Although the clinicopathologic staging is the golden criterion for the prognosis at present, the optimum prognostic criteria for colorectal cancer should be a combination of the clinicopathologic staging and the molecular markers. However, there are currently no molecular markers available for the prognosis of colorectal cancer. Several tumor-suppressor genes associated with colorectal cancer have been mapped at the 18q21-23 region. In this study we detected the frequency of loss of heterozygosity (LOH) at chromosome 18q and investigated the relationship between LOH and clinicopathologic features and its prognostic value for patients with stage II colon cancer. METHODS:A total of 106 samples of tumor tissues and corresponding normal mucosa from patients with sporadic stage-II colon cancer were included in this study. All the samples were formalin-fixed and paraffin-embedded. DNA was extracted from tumor tissues and LOH of D18S474, D18S55, D18S58, D18S61 and D18S64 at chromosome 18q was analyzed using polymerase chain reaction (PCR), polyacrylamide gel-electrophoresis, and DNA sequencing method. Multivariate analysis for association between LOH and prognosis in colon cancer patients was performed with Cox proportional hazards regression model. RESULTS:The median follow-up time was 68 months. For 106 patients, 5-year survival rate was 83.6%, which was associated with age and gross tumor type (P = 0.011 and 0.034, respectively). Among 102 patients who were eligible for LOH information, the overall frequency of LOH is 49.0% (50/102), and that of LOH at 5 microsatellite loci of D18S474, D18S55, D18S58, D18S61, and D18S64 was 30.2% (26/86), 23.4% (18/77), 28.6% (20/70), 35.0% (28/80), and 20.8%(15/72), respectively. The occurrence of LOH was significantly associated with tumor location and histopathologic grade (P = 0.023, 0.016 and 0.005, respectively). LOH was more frequent on the left-side, poorly-differentiated adenocarcinoma, and nonmucinous colon cancers. The occurrence of 18q-LOH was significantly associated with 5-year overall survival rate and disease free survival rate (P = 0.008 and 0.006, respectively). The occurrence of 18q-LOH at the loci of D18S474 and D18S61 was significantly associated with 5-year overall survival rate (P = 0.010 and 0.005, respectively). The multivariate analysis showed that only the occurrence of 18q-LOH was significantly associated with prognosis (P = 0.021). CONCLUSIONS:There is a high occurrence of LOH at the loci of 18q. The expression of LOH is significantly associated with tumor location and histopathologic grade. The occurrence of 18q-LOH is an independent poor prognostic factor for the patients with stage-II colon cancer.

[Loss of Heterozygosity on Chromosome 12P12-13 Region in Chinese Patients with Colon Carcinoma].

Loss of heterozygosity on long arm of chromosome 22 in sporadic colorectal carcinoma.

Detailed Deletion Mapping of Loss of Heterozygosity on 22q13 in Sporadic Colorectal Cancer

The Study of Loss of Heterozygosity of D22S274 on 83 Sporadic Colorectal Carcinomas

Loss of Heterozygosity of Chromosome 20 in Sporadic Colorectal Cancer.

[Refined Mapping of Loss of Heterozygosity of 1P36.33-36.31 in Sporadic Colorectal Carcinoma].

[Refined Mapping of Loss of Heterzygosity on 10Q23-24 in Sporadic Colorectal Carcinoma].

Refined Mapping of Loss of Heterzygosity on Chromosome 1 in Sporadic Colorectal Carcinoma

[Loss of Heterozygosity Analysis to Define Putative Region Involved in Tumor Differentiation and Metastases in Sporadic Colorectal Cancer Patients].

[Refined Deletion Mapping of Loss of Heterozygosity on 22q13 in Sporadic Colorectal Carcinoma].

Loss of Heterozygosity on Chromosome 3p in Breast Cancer and Precancerous Lesion

Mutations in KRAS Codon 12 Predict Poor Survival in Chinese Patients with Metastatic Colorectal Cancer.

Correlation analysis between loss of heterozygosity at chromosome 18q and prognosis in the stage-II colon cancer patients.

Loss of Heterozygosity on Chromosome 10Q22-10Q23 and 22q 11.2- 22q 12.1 and P53 Gene in Primary Hepatocellular Carcinoma

Genome-Wide Search for Loss of Heterozygosity in Chinese Patients with Sporadic Colorectal Cancer

Loss of heterozygosity analysis of long arm of chromosome 4 in sporadic colorectal carcinoma

KRAS, BRAF and PIK3CA Mutations and the Loss of PTEN Expression in Chinese Patients with Colorectal Cancer.

Microsatellite Alteration and Its Characteristics in Colorectal Carcinoma

Preliminary study on the loss of heterozygosity at 17p13 in gastric and colorectal cancers.

Allelic loss is heterogeneous throughout the tumor in colorectal carcinoma

Loss of Heterzygosity on Choromsome 4 in Sporadic Colorectal Carcinoma